Table 1.
Study measure | Study type and collection timepoint |
|||
---|---|---|---|---|
cohort study | cross-sectional study | |||
baseline | 3 months | 9 months | ||
Demographics | ||||
Age in years | × | × | ||
Race/ethnicity | × | × | ||
Sex at birth | × | × | ||
Gender identity | × | × | ||
Highest level of education | × | × | ||
Employment status | × | × | ||
Veteran status | × | × | ||
Health insurance | × | × | ||
Annual family income in the last year | × | × | ||
ZIP code | × | × | ||
General health | ||||
Overall health status (Short Form [SF-8] Health Survey) [12, 13] | × | × | × | × |
Depression (PHQ-8) [14, 15] | × | × | × | × |
Anxiety (GAD-7) [16] | × | × | × | × |
PTSD (adapted from DSM-5 [PC-PTSD-5]) [17, 18] | × | × | × | × |
Pain (BPI) [19] | × | × | × | × |
Quality of sleep (single item adapted from PSQI) [20] | × | × | × | × |
Positive affect (PROMIS) [21, 22] | × | × | × | |
Anger (PROMIS) [21, 22] | × | × | × | |
History of cannabis use (including cannabis obtained without a medical card in Florida) | ||||
Ever used during a lifetime | × | |||
Age when used for the first time | × | × | ||
Weekly use | × | × | ||
Number of years used weekly | × | × | ||
Daily use | × | × | ||
Number of years used daily | × | × | ||
Cannabis use experience level | × | |||
Cannabis products ever tried before medical cannabis | × | |||
Cannabis use in the last 6 months | × | |||
Frequency of cannabis use in past 6 months (from CUDIT-R) [23] | × | × | × | |
Frequency of cannabis use in past 3 months (from CUDIT-R) [23] | × | |||
Frequency of cannabis use per day in an average use day | × | |||
Flower use in the past 30 days | × | |||
Frequency of flower use in the past 30 days | × | |||
Frequency of flower use per day in an average use day | × | |||
Ever used CBD | × | |||
Frequency of CBD use in past 6 months | × | |||
Amount of money spent on cannabis in a typical month | × | |||
Alcohol and other substance use | ||||
Alcohol use (AUDIT-C) [24] | × | × | × | × |
Cigarette smoking use (from BRFSS) [25] | × | × | × | |
E-cigarette/vape use (from BRFSS) [25] | × | × | × | |
Frequency of opioid use (with prescription) in past 30 days | × | × | × | |
Frequency of opioid use (without prescription) in past 30 days | × | × | × | |
Frequency of benzodiazepine use (with prescription) in past 30 days | × | × | × | |
Frequency of benzodiazepine use (without prescription) in past 30 days | × | × | × | |
Frequency of amphetamine use (with prescription) in past 30 days | × | × | × | |
Frequency of amphetamine use (with prescription) in past 30 days | × | × | × | |
Frequency of cocaine/crack use in past 30 days | × | × | × | |
Frequency of hallucinogens use in past 30 days | × | × | × | |
Frequency of synthetic cannabis use in past 30 days | × | × | × | |
Frequency of kratom use in past 30 days | × | × | × | |
Use of recreational substance to track | × | |||
Substance name to track (up to 3 substances) | × | |||
Change in substance tracked | × | × | ||
Use of (alcohol, cigarettes, vapes, cocaine, hallucinogens, club drugs, synthetic cannabis, and kratom) in past 5 years | × | |||
Change in (alcohol, cigarettes, vapes, cocaine, hallucinogens, club drugs, synthetic cannabis, kratom) since starting medical cannabis | × | |||
Is change in use (alcohol, cigarettes, vapes, cocaine, hallucinogens, club drugs, synthetic cannabis, kratom) related to medical cannabis? | × | |||
Use of (opioids with and without prescription, amphetamines with and without prescription, benzodiazepines with and without prescription) in the past 5 years | × | |||
Change in (opioids with and without prescription, amphetamines with and without prescription, benzodiazepines with and without prescription) since starting medical cannabis | × | |||
Is change in use (opioids with and without prescription, amphetamines with and without prescription, benzodiazepines with and without prescription) related to medical cannabis? | × | |||
Medications | ||||
List of current medications (medication name, dose, frequency of use, and route of administration) | × | × | × | × |
Use of medications to track | × | |||
Medications names to track (up to 3) | × | |||
Change in medications tracked | × | × | ||
Tried to reduce specific medications in past 5 years | × | |||
Name of 3 medications tried to reduce in past 5 years | × | |||
Overall change of medication use since starting medical cannabis | × | |||
Is a change in medication use related to medical cannabis? | × | |||
Medical conditions | ||||
Medical conditions diagnosed by healthcare professional | × | × | ||
Cancer: type of cancer | × | × | ||
Cancer: metastasis | × | × | × | × |
Cancer: current cancer status | × | × | × | × |
Cancer: current cancer treatment | × | × | × | × |
Medical cannabis effect on medical conditions | × | × | × | |
Method of cannabis use that was most effective for each condition | × | × | × | |
Name of product that works best for each condition | × | × | × | |
Other health benefits of medical cannabis | × | × | × | |
Knowledge of care providers about medical cannabis use | × | × | × | |
Cancer: knowledge of oncologist/provider about use/intent to use | × | × | × | × |
Reasons for using or stopping medical cannabis | ||||
Medical conditions that are reasons for medical cannabis use | × | × | ||
Certified medical condition | × | × | ||
Cancer: cancer-specific reason for use | × | × | ||
Cannabis use motive (recreational vs. medical) | × | × | × | × |
Reasons for stopping | × | × | ||
Thinking about stopping use | × | × | ||
Reasons for thinking about stopping use | × | × | ||
Expectations | ||||
Expected effectiveness | ||||
Concern about addiction/dependence on medical cannabis | × | × | × | × |
Likelihood to be taking cannabis in a year | × | × | × | × |
Duration of medical cannabis use | ||||
Still using medical cannabis | × | × | ||
Duration of medical cannabis use | × | × | × | |
Duration of use before stopping | × | × | ||
Year first obtained medical cannabis card in Florida | × | |||
Medical cannabis products | ||||
Products tried from the medical cannabis program in Florida (flower, vaporizer cartridges or vape pen (liquid, not flower), concentrates (for vaping or smoking), topicals, oral tinctures (with a dropper), oral concentrates, oral capsules or edibles (chews, lozenges, chocolates, or gels), other | × | × | × | |
Products used in the past 30 days (all products) | × | × | × | |
Reasons for not using the product (all products) | × | × | × | |
Frequency of product use in past 30 days | × | × | × | |
Frequency of product use in a typical day (all products) | × | × | × | |
THC concentration (all products) | × | × | × | |
Duration to effect onset (all products) | × | × | × | |
Duration of effects to last (all products) | × | × | × | |
CBD: THC ratio (all products) | × | × | × | |
Number of strains tried (all products) | × | × | × | |
Strain used most (all products) | × | × | × | |
Duration to consume one flower container | × | × | × | |
Number of flower containers used per month | × | × | × | |
Frequency of methods to consume flower in past 30 days (smoking, vaping, cooking) | × | × | × | |
Number of hits, tokes, or puffs per session when smoking/vaping flower/cartridges/concentrates | × | × | × | |
Number of seconds when inhaling smoke or vape | × | × | × | |
Frequency of using concentrate methods in past 30 days (shatter, rosin, wax, keif, crumble, dab tab, hash) | × | × | × | |
Frequency of using at least 25 mg (rice-sized) of concentrate in past 30 days | × | × | × | |
Frequency of using topical methods in past 30 days (patch, cream, lotion, balms, salves, spray, transdermal gel, oil) | × | × | × | |
Milliliters of tincture consumed per occasion | × | × | × | |
Average milligrams of THC and CBD consumed when using tinctures | ||||
Frequency of using oral concentrate methods in past 30 days (distillate syringe, RSO syringe) | × | × | × | |
Amount of oral concentrate per occasion | × | × | × | |
Frequency of oral methods in past 30 days (capsule/tablets, gel/gummies, brownie/cookie) | × | × | × | |
Amount spent on products per month in USD | × | × | × | |
Overall preferred medical cannabis and/or a product type or strain | × | × | × | |
Preferred method of using medical cannabis | × | × | × | |
Name of overall preferred strain/product | × | × | × | |
Amount of used cannabis from a Florida dispensary | × | × | ||
Side effects | ||||
Symptoms bothered by in the past 2 weeks | × | × | × | × |
Were symptoms caused by medical cannabis? | × | × | × | |
Severe side effects requiring an emergency room visit, seeing a physician, being hospitalized, or feeling extremely sick for a few hours | × | × | × | |
Describe severe side effects | × | × | × | |
Frequency of severe side effects | × | × | × | |
Concurrent use of substance/medication when severe side effect occurred | × | × | × | |
Mode of consumption when severe side effect occurred | × | × | × | |
Cannabis use disorder (CUDIT-R) [23] | × | × | × | × |
Beliefs and opinions | ||||
Agree that cannabis products with high THC will be more effective | × | × | × | × |
Preference to try low-THC products | × | × | × | × |
Importance of CBD in the medical effects of medical cannabis | × | × | × | × |
Importance of including terpenes in medical cannabis products | × | × | × | × |
Factors influencing products tried | × | × | × | |
Interest in growing own medical cannabis if it becomes legal in Florida | × | × | × | |
Additional topics that should be researched | × | × |
AUDIT-C, Alcohol Use Disorders Identification Test-Concise [24]; BPI, Brief Pain Inventory [19]; BRFSS, Behavioral Risk Factor Surveillance System [25]; CBD, cannabidiol; CUDIT-R, Cannabis Use Disorders Identification Test-Revised [23]; DSM-5 (PC-PTSD-5), Primary Care Posttraumatic Stress Disorder Screen for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition [17, 18]; GAD-7, General Anxiety Disorder-7 [16]; PHQ-8, eight-item Patient Health Questionnaire depression scale [14, 15]; PTSD, posttraumatic stress disorder [17, 18]; PROMIS, Patient-Reported Outcomes Measurement Information System [21, 22]; PSQI, Pittsburgh Sleep Quality Index [20]; SF-8, Short Form 8 [12, 13]; THC, tetrahydrocannabinol.